Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2023-4897— Relative Path Traversal in mintplex-labs/anything-llm

EPSS 0.06% · P20
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2023-4897

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Relative Path Traversal in mintplex-labs/anything-llm
Source: NVD (National Vulnerability Database)
Vulnerability Description
Relative Path Traversal in GitHub repository mintplex-labs/anything-llm prior to 0.0.1.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
相对路径遍历
Source: NVD (National Vulnerability Database)
Vulnerability Title
AnythingLLM 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
AnythingLLM是符合业务要求的文档聊天机器人。 AnythingLLM 0.0.1之前版本存在安全漏洞,该漏洞源于存在相对路径遍历。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

VendorProductAffected VersionsCPESubscribe
mintplex-labsmintplex-labs/anything-llm unspecified ~ 0.0.1 -

II. Public POCs for CVE-2023-4897

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2023-4897

登录查看更多情报信息。

Same Patch Batch · mintplex-labs · 2023-09-11 · 3 CVEs total

CVE-2023-4899SQL Injection in mintplex-labs/anything-llm
CVE-2023-4898Authentication Bypass by Primary Weakness in mintplex-labs/anything-llm

IV. Related Vulnerabilities

V. Comments for CVE-2023-4897

No comments yet


Leave a comment